THURSDAY, Nov. 6 (HealthDay News) -- Even though orally delivered “sublingual immunotherapy” (SLIT) is used to treat allergies in a number of countries, there are unanswered questions about its effectiveness, appropriate use, dosage and safety of administration, according to experts at the annual meeting of the American College of Allergy, Asthma & Immunology (ACAAI), in Seattle.
